CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia. - Test2 - elhamkhani - TriplyDB

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37625487

about

Transcriptomic assay of CD8+ T cells in treatment-naïve HIV, HCV-mono-infected and HIV/HCV-co-infected Chinese.Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia.CD160 is essential for NK-mediated IFN-γ production The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation STAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.Differential and tumor-specific expression of CD160 in B-cell malignancies.Aberrantly activated anti-apoptotic signalling mechanisms in chronic lymphocytic leukaemia cells: clues to the identification of novel therapeutic targets.Targeting costimulatory molecules to improve antitumor immunity.Regulation of normal and leukemic stem cells through cytokine signaling and the microenvironment.CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression.Idelalisib Impacts Cell Growth through Inhibiting Translation-Regulatory Mechanisms in Mantle Cell Lymphoma.

P2860

Q34428339-AB28FCEA-C1CE-41C6-97A4-1F1E0BBE0F2E Q35040222-4DFCB9FB-F78B-455A-8C5D-4B92BCBAC01A Q35161483-16E16180-F8BD-4CF2-B4FB-7D50F9373469 Q36053977-4EBF6F49-46C4-4FAE-8EF0-F5A9AACBD238 Q37362593-04BAED31-211F-4A76-9386-894F734A78E7 Q37625491-9606A6E0-E7D5-49A1-8CDD-9899BAF7F96C Q37866334-534EEFAD-4DD4-4507-936F-E43B7B81AB93 Q38002404-237826CF-3B1C-44D4-9D86-26DB028E35EF Q39125504-5D1BFF04-DCF2-4D91-9B73-EE471D484E34 Q41726535-A569B911-6114-419E-9EAD-40F213F729AC Q51682819-39A93CFF-D0B5-4B6F-8219-A548C42EC355

P2860

CD160 signaling mediates PI3K-dependent survival and growth signals in chronic lymphocytic leukemia.

http://www.wikidata.org/entity/Q37625487

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 17 February 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

CD160 signaling mediates PI3K- ...... chronic lymphocytic leukemia.

@en

CD160 signaling mediates PI3K- ...... chronic lymphocytic leukemia.

@nl

type

label

CD160 signaling mediates PI3K- ...... chronic lymphocytic leukemia.

@en

CD160 signaling mediates PI3K- ...... chronic lymphocytic leukemia.

@nl

prefLabel

CD160 signaling mediates PI3K- ...... chronic lymphocytic leukemia.

@en

CD160 signaling mediates PI3K- ...... chronic lymphocytic leukemia.

@nl

P1433

Q37625487-421037C7-DE67-4722-90A0-5392D2BD687E

P1476

Q37625487-94985C90-B1B9-432E-BA68-53D13AB1A0C6

P2093

Q37625487-5B0AE879-D4A5-4C44-8E3A-FB0B13621D3F

Q37625487-BC3DE400-858F-4F8E-8902-846C5AB029FA

Q37625487-D957C489-4037-49D7-B9CB-9B79D565A74C

P2860

Q37625487-0744DF5C-1CC1-471E-B99B-724F23B887B8

Q37625487-0A0B0666-A237-4C96-9390-8932A8BCAE20

Q37625487-0A5282D2-6A77-46EA-BDF0-EA5A01002AE9

Q37625487-13C2C849-45CA-482A-9E81-AD942C90D913

Q37625487-14D2C734-7C81-4714-A617-B9F4D1106D44

Q37625487-1DC52A62-7862-4EB2-B8F4-D77140E52C5F

Q37625487-2F147E64-26CA-41FB-8EDA-FA9C53C9E41C

Q37625487-35C3C165-C1D5-4B7A-A7A6-FC18FDE2BDC8

Q37625487-368C45E7-AEFD-46E0-AA8C-2E4B6F9F7B61

Q37625487-3BBFAC14-1840-40F4-AEDD-903A22FD5DF0

P304

Q37625487-C8B3204A-1CC5-4913-9828-91FBD874977C

P31

Q37625487-CEDD9A4E-0837-4466-B7EC-CB22CB8A94F1

P356

Q37625487-E5FB926D-6B90-4E2D-8146-CBA706678719

P407

Q37625487-B79A877F-55C7-49A1-8BC8-7866463A3129

P433

Q37625487-0FD632FE-7EF2-449A-BFF2-A0B337005010

P478

Q37625487-93467ABB-CAC6-4480-8ABB-2D13E9D8927D

P50

Q37625487-15E54061-22D9-4711-9645-BA0BE304237D

Q37625487-5E40A930-9108-44FB-9787-F8FA42F3287A

Q37625487-7E97CC75-535E-45FC-9FA4-670BB0CD965B

Q37625487-CDB2B923-7F04-450C-8A36-9719E2016C41

P577

Q37625487-FE499DA5-85AC-4BC2-BA31-09C88C586502

P5875

Q37625487-D1A17F81-23F3-422A-B731-97CF83C777E8

P698

Q37625487-10A6DC04-CF1D-4844-AC42-0B4DF73FC76C

P921

Q37625487-64F46823-F2B8-48F9-B648-FB776EBF10FC

Q37625487-A97EC1BA-02FA-4481-B6E1-9A2158B6ACD8

P932

Q37625487-BB914640-22F4-48D5-8F1A-6046AD8FF449

P356

BLOOD-2009-08-239483

P1433

P1476

CD160 signaling mediates PI3K- ...... n chronic lymphocytic leukemia

@en

P2093

John G Gribben

http://www.w3.org/2001/XMLSchema#string

Samir G Agrawal

http://www.w3.org/2001/XMLSchema#string

Timothy Farren

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells

Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset

Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes

Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity.

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

PI3K in lymphocyte development, differentiation and activation

Synthesis and function of 3-phosphorylated inositol lipids

BY55/CD160 acts as a co-receptor in TCR signal transduction of a human circulating cytotoxic effector T lymphocyte subset lacking CD28 expression

Differential Noxa/Mcl-1 balance in peripheral versus lymph node chronic lymphocytic leukemia cells correlates with survival capacity

Identification of a novel CD160+ CD4+ T-lymphocyte subset in the skin: a possible role for CD160 in skin inflammation

P304

3079-3088

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2009-08-239483

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

115

http://www.w3.org/2001/XMLSchema#string

P50

Armand Bensussan

Jérôme Giustiniani

P577

2010-02-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41466014

http://www.w3.org/2001/XMLSchema#string

P698

20164468

http://www.w3.org/2001/XMLSchema#string

P921

P932

5292590

http://www.w3.org/2001/XMLSchema#string